MACPAC report on utilization of management controls on the treatment of opioid use disorder under Medicaid

Not later than 1 year after the date of enactment of this section, the Medicaid and CHIP Payment and Access Commission shall submit to Congress a report on issues related to utilization management controls for medication-assisted treatment of opioid use disorder under the Medicaid program. Such report shall include— (1) an analysis and description of the use of utilization management controls for medication-assisted treatment furnished through the Medicaid program across all States (as defined in section 1101(a)(1) of the Social Security Act (42 U.S.C. 1301(a)(1)) for purposes of title XIX of such Act), including dosing restrictions, age limits, counseling requirements, and psychological screening requirements; (2) an assessment of the extent to which such utilization management controls impose an administrative burden on clinicians and other providers; and (3) an assessment of other Medicaid policies, at both the Federal and State level, that impede patient access to medication-assisted treatment and complicate clinician or provider prescribing practices.